50,735 Amdocs Limited $DOX Shares Sold by Boston Trust Walden Corp

Boston Trust Walden Corp lessened its position in shares of Amdocs Limited (NASDAQ:DOX) by 92.9% in the third quarter, HoldingsChannel.com reports. The firm owned 3,900 shares of the technology company’s stock after selling 50,735 shares during the quarter. Boston Trust Walden Corp’s holdings in Amdocs were worth $223,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Covestor Ltd boosted its position in shares of Amdocs by 11.8% during the 3rd quarter. Covestor Ltd now owns 2,461 shares of the technology company’s stock worth $141,000 after purchasing an additional 259 shares in the last quarter. Pzena Investment Management LLC boosted its holdings in Amdocs by 3.4% in the third quarter. Pzena Investment Management LLC now owns 14,454,911 shares of the technology company’s stock worth $826,532,000 after acquiring an additional 469,581 shares in the last quarter. Greenleaf Trust grew its stake in Amdocs by 32.3% in the third quarter. Greenleaf Trust now owns 5,258 shares of the technology company’s stock valued at $301,000 after acquiring an additional 1,283 shares during the period. Mirae Asset Global Investments Co. Ltd. acquired a new stake in Amdocs in the third quarter valued at approximately $57,000. Finally, D.A. Davidson & CO. bought a new stake in shares of Amdocs during the third quarter valued at approximately $213,000. Institutional investors and hedge funds own 92.02% of the company’s stock.

Amdocs Stock Performance

NASDAQ:DOX traded down $1.74 on Friday, reaching $42.09. 4,358,971 shares of the company’s stock were exchanged, compared to its average volume of 946,788. The stock has a fifty day simple moving average of $59.49 and a 200-day simple moving average of $61.98. The company has a debt-to-equity ratio of 0.23, a current ratio of 0.94 and a quick ratio of 0.94. Amdocs Limited has a 52 week low of $40.48 and a 52 week high of $85.63. The firm has a market cap of $4.54 billion, a price-to-earnings ratio of 9.01, a P/E/G ratio of 1.01 and a beta of 0.42.

Amdocs (NASDAQ:DOX) last announced its quarterly earnings results on Tuesday, November 3rd. The technology company reported $1.98 EPS for the quarter, meeting the consensus estimate of $1.98. Amdocs had a net margin of 9.75% and a return on equity of 20.28%. The firm had revenue of $1.19 billion during the quarter, compared to the consensus estimate of $1.19 billion. During the same period last year, the firm earned $1.83 EPS. The business’s quarterly revenue was up 3.8% compared to the same quarter last year. As a group, sell-side analysts predict that Amdocs Limited will post 7.12 earnings per share for the current year.

Amdocs Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 29th. Shareholders of record on Thursday, December 31st will be paid a $0.5690 dividend. The ex-dividend date of this dividend is Thursday, December 31st. This represents a $2.28 annualized dividend and a yield of 5.4%. Amdocs’s payout ratio is currently 48.82%.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on DOX shares. Stifel Nicolaus lowered their target price on Amdocs from $71.00 to $46.00 and set a “buy” rating on the stock in a research report on Wednesday. Oppenheimer lowered shares of Amdocs from an “outperform” rating to a “market perform” rating in a research note on Wednesday. Weiss Ratings upgraded shares of Amdocs from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, October 23rd. Finally, Wall Street Zen cut shares of Amdocs from a “buy” rating to a “hold” rating in a report on Saturday. Three analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $78.33.

Amdocs Company Profile

Amdocs Ltd. (NASDAQ: DOX) is a global provider of software and technology services for communications, media and entertainment companies. Its solutions help service providers manage customer relationships, billing, subscriptions, product offerings and digital experiences across consumer and enterprise markets.

The company’s portfolio includes business support systems and operational support systems, cloud-based software, artificial intelligence and automation tools, network and service management platforms, and solutions for media distribution and monetization.